Press Releases
Search
-
27 Jul 2005
DiagnoSwiss and bioMérieux announce that they have signed an exclusive license agreement for the development and use of DiagnoSwiss electrochemical microchips in human in vitro diagnostics
Marcy l’Etoile - July 27, 2005. Monthey (Switzerland) – Marcy l’Etoile (France), July 27, 2005 – bioMérieux and DiagnoSwiss announced today that DiagnoSwiss has granted bioMérieux with an exclusive wo...
-
20 Jul 2005
First half 2005 sales up 4.0%, second quarter up 7.8%, excluding the currency effect
Marcy l'Etoile, France - 20 July 2005. bioMérieux, a global leader in the field of in vitro diagnostics, today announced its first-half 2005 sales.
-
05 Jul 2005
Hepanostika® HBsAg Ultra – New “ultra”-sensitive test for Hepatitis B infection from bioMérieux
Marcy l’Etoile, France - July 5th, 2005. bioMérieux, a world leader in the field of in vitro diagnostics, announces the launch of its new microelisa assay for the detection of hepatitis B surface anti...
-
23 Jun 2005
Hospices Civils de Lyon and bioMérieux inaugurate a joint immunogenomics and inflammation unit
Lyon, France - June 23, 2005. Hospices Civils de Lyon (HCL) and bioMérieux will inaugurate today the “HCL-bioMérieux” joint unit dedicated to research in immunogenomics and inflammation. The unit is h...
-
07 Jun 2005
NucliSens® easyMAG™ – new innovation from bioMérieux for nucleic acid extraction
Marcy l'Etoile - France - June 7th, 2005. A world leader in the field of in vitro diagnostics, bioMérieux announces the launch of its new automated sample preparation platform for the extraction of nu...
-
25 May 2005
25/05/2005 - MRSA ID - bioMérieux’s latest contribution to the fight against nosocomial infections
Marcy l’Etoile, France - May 25th, 2005. A world leader in the field of in vitro diagnostics, bioMérieux SA announces the launch of a new product for rapid, reliable identification of Methicillin-Resi...